Genovis AB (publ.) logo

Genovis AB (publ.)

SSE:GENO.ST

Overview | Financials
Company Name Genovis AB (publ.)
Symbol GENO.ST
Currency SEK
Price 43.5
Market Cap 2,847,757,950
Dividend Yield 0%
52-week-range 35.6 - 71.3
Industry Biotechnology
Sector Healthcare
CEO Mr. Fredrik Olsson
Website https://www.genovis.com

An error occurred while fetching data.

About Genovis AB (publ.)

Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the

Related Stocks

Sedana Medical AB (publ) logo

Sedana Medical AB (publ)

SEDANA.ST

16.85 SEK

Probi AB (publ) logo

Probi AB (publ)

PROB.ST

203 SEK

Bonesupport Holding AB (publ) logo

Bonesupport Holding AB (publ)

BONEX.ST

189.8 SEK

Bactiguard Holding AB (publ) logo

Bactiguard Holding AB (publ)

BACTI-B.ST

84.4 SEK

Attendo AB (publ) logo

Attendo AB (publ)

ATT.ST

37.8 SEK

Hansa Biopharma AB (publ) logo

Hansa Biopharma AB (publ)

HNSA.ST

32.64 SEK

BioInvent International AB (publ) logo

BioInvent International AB (publ)

BINV.ST

16.58 SEK

Q-linea AB (publ) logo

Q-linea AB (publ)

QLINEA.ST

2.49 SEK

Humana AB (publ) logo

Humana AB (publ)

HUM.ST

27 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD